MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
Thrasos Secures $21 Million to Complete Phase 2 Study of THR-184 in the Prevention of Acute Kidney Injury and Expand the Company's Renal Portfolio.
Brennan CaruthersMarch 31, 2015
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

Thrasos Completes Enrollment of Phase 2 THR-184 Clinical Studay for Acute Kidney Injury.

Brennan CaruthersJuly 7, 2015
Next

F-star Announces the Formation of Second Asset-Centric Vehicle, F-star Beta Ltd.

Brennan CaruthersNovember 4, 2014

© 2010-2019 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact